Residual vectors for Alzheimer disease diagnosis and prognostication

Brain and Behavior

Volumn 1, Issue 2, 2011, Pages 142-152

  Clark, David Glenn ^a,b  

^a BIRMINGHAM VA MEDICAL CENTER   (United States)

^b The University of Alabama at Birmingham   (United States)

Author keywords

ADNI; Alzheimer disease; Bioinformatics; Mild cognitive impairment; PET scan

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

AGED; ALZHEIMER DISEASE; ARTICLE; AUTOMATION; CONTROLLED STUDY; FEMALE; FUNCTIONAL ACTIVITIES QUESTIONNAIRE; HUMAN; INFORMATION PROCESSING; INFORMATION RETRIEVAL; MAJOR CLINICAL STUDY; MALE; MILD COGNITIVE IMPAIRMENT; POSITRON EMISSION TOMOGRAPHY; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; QUESTIONNAIRE; SCORING SYSTEM; SENSITIVITY AND SPECIFICITY;

EID: 84874591136     PISSN: 21623279     EISSN: 21579032     Source Type: Journal    
DOI: 10.1002/brb3.19     Document Type: Article

References (25)

1. Casey, M. A., R. Veltkamp, M. Goto, M. Leman, C. Rhodes, and M. Slaney. 2008. Content-based information retrieval: current directions and future challenges. Proc. IEEE 96:668-696.
2. Chetelat, G., B. Desgranges, V. de la Sayette, F. Viader, F. Eustache, and J. C. Baron. 2003. Mild cognitive impairment: can FDG-PET predict who is to rapidly convert to Alzheimer's disease? Neurology 60:1374-1377.
3. Cuingnet, R., E. Gerardin, J. Tessieras, G. Auzias, S. Lehericy, M.-O. Habert, et al. 2010. Automatic classification of patients with Alzheimer's disease from structural MRI: A comparison of ten methods using the ADNI database. NeuroImage 56:766-781.
4. Datta, R., D. Joshi, J. Li, and J. Z.Wang. 2008. Image retrieval: ideas, influences, and trends of the new age. ACM Comput. Surv. 40:5:1-5:60.
5. Drzezga, A., T. Grimmer, M. Riemenschneider, N. Lautenschlager, H. Siebner, P. Alexopoulos, S. Minoshima, M. Schwaiger, and A. Kurz. 2005. Prediction of individual clinical outcome in MCI by means of genetic assessment and 18F-FDG PET. J. Nucl. Med. 46:1625-1632.
6. Feldman, H. H., S. Ferris, B.Winblad, N. Sfikas, L. Mancione, Y. He, et al. 2007. Effect of rivastigmine on delay to diagnosis of Alzheimer's disease from mild cognitive impairment: the InDDEx study. Lancet Neurol. 6:501-512.
7. Foster, N. L., J. L.Heidebrink, C. M. Clark, W. J. Jagust, S. E. Arnold, N. R. Barbas, et al. 2007. FDG-PET improves accuracy in distinguishing frontotemporal dementia and Alzheimer's disease. Brain 130:2616-2635.
8. Greicius, M. D., G. Srivastava, A. Reiss, and V. Menon. 2004. Default-mode network activity distinguishes Alzheimer's disease from healthy aging: evidence from functional MRI. Proc. Natl. Acad. Sci. 101:4637-4642.
9. Greicius, M. D., K. Supekar, V.Menon, and R. F. Dougherty. 2008. Resting-state functional connectivity reflects structural connectivity in the default mode network. Cereb. Cortex 19:72-78.
10. Hebert, L. E., P. A. Scherr, J. L. Bienias, D. A. Bennet, and D. A. Evans. 2003. Alzheimer Disease in the US population. Prevalence estimates using the 2000 census. Arch. Neurol. 60:1119-1122.
11. Landau, S.M., D. Harvey, C. M. Madison, R. A. Koeppe, et al. 2011. Associations between cognitive, functional, and FDG-PET measures of decline in AD and MCI. Neurobiol. Aging 32(7): 1207-1218.
12. Landau, S.M., D. Harvey, C. M. Madison, and E. M. Reiman. 2010. Comparing predictors of conversion and decline in mild cognitive impairment. Neurology 75:230-238.
13. McKhann, G., D. Drachman, M. Folstein, R. Katzman, D. Price, and E. Stadian. 1984. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA work group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 34:939-944.
14. Minoshima, S., K. A. Frey, R. A. Koeppe, N. L. Foster, and D. E. Kuhl. 1995. A diagnostic approach in Alzheimer's disease using three-dimensional stereotactic surface projections of fluorine-18-FDG PET. J. Nucl. Med. 36:1238-1248.
15. Mosconi, L., W. H. Tsui, A. Pupi, S. De Santi, A. Drzezga, S. Minoshima, and M. J. de Leon. 2007. 18F-FDG PET database of longitudinally confirmed healthy elderly individuals improves detection of mild cognitive impairment and Alzheimer's disease. J. Nucl. Med. 48:1129-1134.
16. Petersen, R. C., R. G. Thomas, M. Grundman, D. Bennett, R. Doody, S. Ferris, et al. 2005. Vitamin E and donepezil for the treatment of mild cognitive impairment. New Engl J Med 352:2379-2385.
17. Raichle, M., A. MacLeod, A. Snyder, W. Powers, D. Gusnard, and G. Shulman. 2001. A default mode for brain function. Proc. Natl. Acad. Sci. 98:676-682.
18. R Development Core Team. 2008. R: a language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria.
19. Salloway, S., S. Ferris, A. Kluger, R. Goldman, T. Griesing, D. Kumar, et al. 2004. Efficacy of donepezil in mild cognitive impairment. Neurology 63:651-657.
20. Silverman, D.H., G. W. Small, C. Y. Chang, C. S. Lu, M. A. Kung de Aburto, W. Chen, et al. 2001. Positron emission tomography in evaluation of dementia. Regional brain metabolism and long-term outcome. J Am. Med. Assoc. 286:2120-2127.
21. Thal, L. J., S. H. Ferris, L. Kirby, G. A. Block, C. R. Lines, E. Yuen, et al. 2005. A randomized, double-blind, study of rofecoxib in patients with mild cognitive impairment. Neuropsychopharmacology 30:1204-1215.
22. Walhovd, K. B., A. M. Fjell, J. Brewer, and L. K. McEvoy. 2010. Combining MR imaging, positron-emission tomography, and CSF biomarkers in the diagnosis and prognosis of Alzheimer disease. Am. J. Neurorad. 31:347-354.
23. Widdows, D., and S. Peters. 2003.Word vectors and quantum logic: experiments with negation and dysjunction. Proceedings of Mathematics of Language 8:141-154.
24. Widdows, D. 2004. Geometry and meaning. CSLI, Stanford, CA.
25. Woods, R. P., S. Grafton, C. Holmes, S. Cherry, and J. C. Mazziotta. 1998. Automated image registration: I. General methods and intrasubject, intramodality validation. J. Comput. Assist. Tomogra. 22:139-152. 152